Sei Investments Co. Has $9.61 Million Stock Position in Ingevity Co. (NYSE:NGVT)

Sei Investments Co. increased its position in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 23.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 235,854 shares of the company's stock after purchasing an additional 44,782 shares during the period. Sei Investments Co. owned 0.65% of Ingevity worth $9,611,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in NGVT. KBC Group NV lifted its holdings in shares of Ingevity by 27.5% in the fourth quarter. KBC Group NV now owns 2,007 shares of the company's stock valued at $82,000 after buying an additional 433 shares during the period. Empowered Funds LLC acquired a new stake in Ingevity in the 4th quarter valued at about $187,000. Teacher Retirement System of Texas bought a new position in shares of Ingevity during the 4th quarter valued at about $237,000. Hennion & Walsh Asset Management Inc. acquired a new position in shares of Ingevity in the 4th quarter worth approximately $239,000. Finally, XTX Topco Ltd bought a new stake in shares of Ingevity in the 3rd quarter worth approximately $260,000. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and lifted their price target for the stock from $62.00 to $65.00 in a research report on Wednesday, February 26th. StockNews.com lowered Ingevity from a "buy" rating to a "hold" rating in a research report on Monday, March 24th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $55.17.

Remove Ads

Ingevity Trading Down 12.4 %

NYSE NGVT traded down $4.89 on Thursday, hitting $34.65. 314,846 shares of the stock were exchanged, compared to its average volume of 268,275. The company's 50-day moving average price is $44.42 and its two-hundred day moving average price is $42.55. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. Ingevity Co. has a 52-week low of $30.90 and a 52-week high of $56.30. The company has a market capitalization of $1.26 billion, a price-to-earnings ratio of -2.93 and a beta of 1.52.

Ingevity (NYSE:NGVT - Get Free Report) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share for the quarter, beating analysts' consensus estimates of $0.29 by $0.66. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. The business had revenue of $298.80 million for the quarter, compared to the consensus estimate of $297.40 million. Research analysts predict that Ingevity Co. will post 4.45 EPS for the current year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.